Dr. Philip George is known for pioneering a new nonsurgical procedure for de-cannulation (removing tracheotomy tubes). His procedure, which improves the quality of life and lowers costs, has become a standard reference for medical students around the world.

Dr. George has conducted double-blind studies on the effects of nutritional supplements for a variety of patients. He has presented papers at international conferences in multiple countries on his research studies about the effects of dairy products on bronchial asthma and the effects of Vitamin B-complex injections for ALS patients.

He has been awarded an honorary Ph.D. in recognition of his research efforts. Dr. Philip George’s accomplishments were honored with inclusion in the 2007-2008 edition of the Heritage Registry of Who’s Who, a New York based biographical publication that selects distinguished individuals throughout North America who have attained a recognizable degree of success in their field of endeavor and thereby contributed to the growth of their industry. Dr. George’s research into the effects of specific vitamins on a variety of diseases has led him to develop of Renervee, a vitamin tablet formulated to benefit patients with various diseases.

With the intention of charity work that goes beyond the borders of all nations, he established Renervee Foundation for Hope.

Candidate for the Nobel Prize in Physiology or Medicine

The Accomplishment Worthy of a Nobel Prize

Patients with tracheostomy tubes who have improved enough to be detached from their ventilators have long been dependent on surgery for removal, or on having a smaller tube placed in the opening as an intermediary step. Both these removal methods can mean a longer stay for the patient in a medical facility and higher health care costs.

Philip George developed a non-invasive protocol for decannulation (removal of tracheostomy tubes) that has revolutionized the process. The first step of George’s new process is to place a Passy-Muir® valve in the tracheostomy tube. This strengthens the patient’s speech muscles and allowed for more normal breathing. The patient is then monitored while using the valve for two days. On the third day, the valve is capped for a brief period, allowing the patient to breathe normally. This valve capping period is gradually extended until the patient can tolerate 48 hours at a stretch. When the patient is comfortable breathing in a normal fashion, the tracheostomy tube is removed, the opening is covered with a special bandage, and the patient is able to return home much sooner than with other removal methods.

This new non-invasive protocol has revolutionized the procedure of decannulation, making it easier and faster for tracheostomy patients to leave care facilities. This results in a greater quality of life for patients and their caregivers, as well as in significant health care cost savings. George’s procedure has now become a standard reference for medical students around the world.

Email : philipg@franklinnh.net

Phone : 646-361-9509